Published in Acta Psychiatr Scand on February 01, 2005
Clozapine versus other atypical antipsychotics for schizophrenia. Cochrane Database Syst Rev (2010) 2.13
Dropout rates in randomized clinical trials of antipsychotics: a meta-analysis comparing first- and second-generation drugs and an examination of the role of trial design features. Schizophr Bull (2008) 1.96
Psychiatric symptoms and quality of life in schizophrenia: a meta-analysis. Schizophr Bull (2007) 1.76
Olanzapine versus other atypical antipsychotics for schizophrenia. Cochrane Database Syst Rev (2010) 1.62
Almost all antipsychotics result in weight gain: a meta-analysis. PLoS One (2014) 1.02
Quality of life in schizophrenic patients. Dialogues Clin Neurosci (2007) 0.96
Subjective effects of antipsychotic treatment. Acta Psychiatr Scand (2005) 0.84
The Scandinavian Solutions for Wellness study - a two-arm observational study on the effectiveness of lifestyle intervention on subjective well-being and weight among persons with psychiatric disorders. BMC Psychiatry (2010) 0.84
Quality of life as patient-reported outcomes: principles of assessment. Dialogues Clin Neurosci (2014) 0.83
The impact of subjective well-being under neuroleptic treatment on compliance and remission. Dialogues Clin Neurosci (2006) 0.82
Prevalence and Predictors of Clozapine-Associated Constipation: A Systematic Review and Meta-Analysis. Int J Mol Sci (2016) 0.78
Preliminary data concerning the reliability and psychometric properties of the Greek translation of the 20-item Subjective Well-Being Under Neuroleptic Treatment Scale (SWN-20). Ann Gen Psychiatry (2009) 0.75
Multidimensional Assessment of Functional Outcomes in Schizophrenia: Results From QUALIFY, a Head-to-Head Trial of Aripiprazole Once-Monthly and Paliperidone Palmitate. Int J Neuropsychopharmacol (2016) 0.75
LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell (2001) 11.99
Analysis of deletions in DNA from patients with Becker and Duchenne muscular dystrophy. Nature (1986) 4.13
Fatal enterovirus 71 encephalomyelitis. J Pediatr (1998) 3.39
The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine. Mol Psychiatry (2006) 2.44
Echocardiography predicts embolic events in infective endocarditis. J Am Coll Cardiol (2001) 2.43
Validity of Euroqol--a generic health status instrument--in patients with rheumatoid arthritis. Economic and Health Outcomes Research Group. Br J Rheumatol (1994) 2.27
Longterm follow-up of patients with pulmonary thromboembolism. Late prognosis and evolution of hemodynamic and respiratory data. Chest (1982) 2.23
Perioperative management of patients with cytoreductive surgery for peritoneal carcinomatosis. J Surg Oncol (2009) 2.14
Behavioural problems in children who weigh 1000 g or less at birth in four countries. Lancet (2001) 2.08
A systematic review of the effectiveness of health service interventions aimed at reducing inequalities in health. J Health Serv Res Policy (1996) 2.08
TMEM132D, a new candidate for anxiety phenotypes: evidence from human and mouse studies. Mol Psychiatry (2010) 2.00
Interleukin-6 in synovial fluid is closely associated with chronic synovitis in rheumatoid arthritis. Rheumatol Int (1993) 1.96
European guidelines on managing adverse effects of medication for ADHD. Eur Child Adolesc Psychiatry (2010) 1.92
Do you see what I see? Weight status misperception and exposure to obesity among children and adolescents. Int J Obes (Lond) (2008) 1.90
Comparison of aerobic exercise, clomipramine, and placebo in the treatment of panic disorder. Am J Psychiatry (1998) 1.86
Population history and its impact on medical genetics in Quebec. Clin Genet (2005) 1.85
Effect of dystrophin gene deletions on mRNA levels and processing in Duchenne and Becker muscular dystrophies. Cell (1990) 1.80
Homozygous familial hypercholesterolemia among French Canadians in Québec Province. Arteriosclerosis (1989) 1.68
Serum interleukin 10 titers in systemic lupus erythematosus reflect disease activity. Lupus (1995) 1.63
[Leishmaniasis and human immunodeficiency virus infections]. Presse Med (1995) 1.61
Familial lipoprotein lipase deficiency in infancy: clinical, biochemical, and molecular study. J Pediatr (1998) 1.60
Rates and predictors of remission and recovery during 3 years in 392 never-treated patients with schizophrenia. Acta Psychiatr Scand (2008) 1.59
Analysis of cell cycle disruptions in cultures of rat pleural mesothelial cells exposed to asbestos fibers. Am J Respir Cell Mol Biol (1997) 1.59
Campylobacter enteritis and erythema nodosum. Lancet (1982) 1.59
A biochemically distinct form of cytochrome oxidase (COX) deficiency in the Saguenay-Lac-Saint-Jean region of Quebec. Am J Hum Genet (1993) 1.57
Improvement of schizophrenic patients' subjective well-being under atypical antipsychotic drugs. Schizophr Res (2001) 1.56
SV40-like DNA sequences in pleural mesothelioma, bronchopulmonary carcinoma, and non-malignant pulmonary diseases. J Pathol (1998) 1.55
Lyme disease presenting as Tourette's syndrome. Lancet (1998) 1.50
Parentification and its impact on adolescent children of parents with AIDS. Fam Process (1999) 1.50
Neurologic crises in hereditary tyrosinemia. N Engl J Med (1990) 1.48
Correlation of severity and outcome with plasma sterol levels in variants of the Smith-Lemli-Opitz syndrome. J Pediatr (1995) 1.46
Impact of present and past antipsychotic side effects on attitude toward typical antipsychotic treatment and adherence. Eur Psychiatry (2004) 1.46
Influence of aspirin on the clinical outcomes of 103 anti-phospholipid antibodies-positive patients. Lupus (2008) 1.45
Metabolic rate, not percent dehydration, predicts rectal temperature in marathon runners. Med Sci Sports Exerc (1991) 1.45
Cognitive dysfunction at baseline predicts symptomatic 1-year outcome in first-episode schizophrenics. Psychopathology (2000) 1.44
Endothelium independent relaxation of human coronary arteries by 17 beta-oestradiol in vitro. Cardiovasc Res (1993) 1.43
Slippery surfaces of pitcher plants: Nepenthes wax crystals minimize insect attachment via microscopic surface roughness. J Exp Biol (2010) 1.43
Deficits in fronto-posterior interactions point to inefficient resource allocation in schizophrenia. Acta Psychiatr Scand (2010) 1.42
Cardiac functional improvement by a human Bcl-2 transgene in a mouse model of ischemia/reperfusion injury. J Gene Med (2001) 1.41
Regional heterogeneity of cerebral blood flow response to graded volume-controlled hemorrhage. Intensive Care Med (1996) 1.40
T-cell subsets and expression of integrins in peripheral blood of patients with migraine. Cephalalgia (1999) 1.40
Clinical, metabolic, and genetic aspects of cytochrome C oxidase deficiency in Saguenay-Lac-Saint-Jean. Am J Hum Genet (1993) 1.40
[Therapeutic options for weight management in schizophrenic patients treated with atypical antipsychotics]. Fortschr Neurol Psychiatr (2008) 1.39
Apparent lack of N-glycosylation in the asexual intraerythrocytic stage of Plasmodium falciparum. Eur J Biochem (1992) 1.38
Medical aspects of ketone body metabolism. Clin Invest Med (1995) 1.37
Imaging of cell/substrate contacts of living cells with surface plasmon resonance microscopy. Biophys J (1999) 1.33
Haemoglobin interferes with the ex vivo luciferase luminescence assay: consequence for detection of luciferase reporter gene expression in vivo. Gene Ther (2000) 1.33
Outcome of individuals with low-moderate methylmalonic aciduria detected through a neonatal screening program. J Pediatr (1999) 1.31
Blood dyscrasias induced by psychotropic drugs. Pharmacopsychiatry (2004) 1.31
Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized, double-blind, placebo-controlled trial with simvastatin. Circulation (2002) 1.29
Perioperative anaphylaxis. Med Clin North Am (2010) 1.29
Hyperadiponectinaemia in anorexia nervosa. Clin Endocrinol (Oxf) (2003) 1.27
Hyperornithinaemia-hyperammonaemia-homocitrullinuria syndrome is caused by mutations in a gene encoding a mitochondrial ornithine transporter. Nat Genet (1999) 1.21
Isolation of Campylobacter hyointestinalis from pigs in the United Kingdom. Vet Rec (1984) 1.21
Mycoplasma pneumoniae infections in a rural setting in Canada. CMAJ (1987) 1.20
Immunological profile in primary Sjögren syndrome: clinical significance, prognosis and long-term evolution to other auto-immune disease. Autoimmun Rev (2010) 1.19
Physical activity vs. sedentary time: independent associations with adiposity in children. Pediatr Obes (2012) 1.19
Genomic, protein homogeneity and antigenic variability of Mycoplasma agalactiae. Vet Microbiol (1996) 1.19
Deletion proximal to DXS68 locus (L1 probe site) in a boy with Duchenne muscular dystrophy, glycerol kinase deficiency, and adrenal hypoplasia. Hum Genet (1988) 1.18
Severe adverse drug reactions of antidepressants: results of the German multicenter drug surveillance program AMSP. Pharmacopsychiatry (2004) 1.16
Administration of medicines by emergency nurse practitioners according to protocols in an accident and emergency department. J Accid Emerg Med (1997) 1.15
Pre-existing arterial stiffness can predict hypotension during induction of anaesthesia in the elderly. Br J Anaesth (2010) 1.15
Rgs 2 gene polymorphisms as modulators of anxiety in humans? J Neural Transm (Vienna) (2006) 1.14
Reshaping a human monoclonal antibody to inhibit human respiratory syncytial virus infection in vivo. Biotechnology (N Y) (1991) 1.13
The Th2-hypothesis of schizophrenia: a strategy to identify a subgroup of schizophrenia caused by immune mechanisms. Med Hypotheses (2001) 1.13
The impact of substance use disorders on clinical outcome in 643 patients with first-episode psychosis. Acta Psychiatr Scand (2005) 1.13
Hexokinase II mRNA and gene structure, regulation by insulin, and evolution. J Biol Chem (1993) 1.13
Broad antitumor and antiangiogenic activities of AG3340, a potent and selective MMP inhibitor undergoing advanced oncology clinical trials. Ann N Y Acad Sci (1999) 1.12
Symptom dimensions in obsessive-compulsive disorder: prediction of cognitive-behavior therapy outcome. Acta Psychiatr Scand (2006) 1.12
Age-related decrease in the inducibility of heat-shock protein 70 in human peripheral blood mononuclear cells. J Clin Immunol (2002) 1.12
Ambient pH signalling in ascomycetous yeasts involves homologues of the Aspergillus nidulans genes palF and paIH. Mol Gen Genet (2000) 1.11
The immune system and schizophrenia. An integrative view. Ann N Y Acad Sci (2000) 1.10
Soil diversity and hydration as observed by ChemCam at Gale crater, Mars. Science (2013) 1.10
Adipocytokines in anorexia nervosa: a review focusing on leptin and adiponectin. Horm Metab Res (2003) 1.10
Age-specific distribution of plasma amino acid concentrations in a healthy pediatric population. Clin Chem (1997) 1.09
Neuropeptide S receptor gene -- converging evidence for a role in panic disorder. Mol Psychiatry (2010) 1.09
Remitted but still impaired? Symptomatic versus functional remission in patients with schizophrenia. Eur Psychiatry (2011) 1.09
Comparison of clinical and echocardiographic characteristics of Streptococcus bovis endocarditis with that caused by other pathogens. Am J Cardiol (2001) 1.08
Mediterranean spotted fever in Belgium. Lancet (1984) 1.06
A mutation in the human lipoprotein lipase gene as the most common cause of familial chylomicronemia in French Canadians. N Engl J Med (1991) 1.06
Evidence for an association between a G-protein beta3-gene variant with depression and response to antidepressant treatment. Neuroreport (2000) 1.06
Elevated serum heat-shock protein 70 levels in patients with acute infection: use of an optimized enzyme-linked immunosorbent assay. Scand J Immunol (2003) 1.06
Safety and tolerance of zolpidem in the treatment of disturbed sleep: a post-marketing surveillance of 16944 cases. Int Clin Psychopharmacol (1998) 1.03
Acute effects of treatment for prodromal symptoms for people putatively in a late initial prodromal state of psychosis. Br J Psychiatry Suppl (2007) 1.02
Reduced brain choline in homocystinuria due to remethylation defects. Neurology (2008) 1.02
Type 1 hereditary tyrosinemia. Evidence for molecular heterogeneity and identification of a causal mutation in a French Canadian patient. J Clin Invest (1992) 1.02
Illegitimate transcription. Application to the analysis of truncated transcripts of the dystrophin gene in nonmuscle cultured cells from Duchenne and Becker patients. J Clin Invest (1991) 1.01
Treated incidence of first-episode psychosis in the catchment area of EPPIC between 1997 and 2000. Acta Psychiatr Scand (2006) 1.00
Gender differences in premorbid, entry, treatment, and outcome characteristics in a treated epidemiological sample of 661 patients with first episode psychosis. Schizophr Res (2009) 1.00
Different patterns of sexual dysfunctions associated with psychiatric disorders and psychopharmacological treatment. Results of an investigation by semistructured interview of schizophrenic and neurotic patients and methadone-substituted opiate addicts. Pharmacopsychiatry (1995) 1.00
More than one mutant allele causes infantile Tay-Sachs disease in French-Canadians. Am J Hum Genet (1990) 0.99
Left-right asymmetry of striatal dopamine D2 receptors. Nucl Med Commun (1998) 0.99
Do emergency physicians save time when locating a live intrauterine pregnancy with bedside ultrasonography? Acad Emerg Med (2000) 0.99
Contractile responses to histamine, serotonin, and angiotensin II are impaired by 17 beta-estradiol in human internal mammary arteries in vitro. Pharmacology (1997) 0.98
Primary sclerosing cholangitis in children. J Pediatr Gastroenterol Nutr (1988) 0.98
Variable expression and geographic distribution of Mycoplasma agalactiae surface epitopes demonstrated with monoclonal antibodies. FEMS Microbiol Lett (1996) 0.98
Intravenous access in the critically ill trauma patient: a multicentered, prospective, randomized trial of saphenous cutdown and percutaneous femoral access. Ann Emerg Med (1994) 0.98